<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">evrazkar</journal-id><journal-title-group><journal-title xml:lang="ru">Евразийский Кардиологический Журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Eurasian heart journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-1685</issn><issn pub-type="epub">2305-0748</issn><publisher><publisher-name>Евразийская ассоциация кардиологов</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2225-1685-2026-2-6-41</article-id><article-id custom-type="elpub" pub-id-type="custom">evrazkar-6599</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GUIDELINES</subject></subj-group></article-categories><title-group><article-title>Евразийские клинические рекомендации по диагностике и лечению кардиоренального синдрома (2026)</article-title><trans-title-group xml:lang="en"><trans-title>Eurasian clinical guidelines for the diagnosis and treatment of cardiorenal syndrome (2026)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9088-721X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Митьковская</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Mitkovskaya</surname><given-names>Nataliya P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Митьковская Наталья Павловна, д.м.н., профессор, заведующая кафедрой кардиологии и внутренних болезней,</p><p>г. Минск.</p></bio><bio xml:lang="en"><p>Nataliya P. Mitkovskaya, Dr. of Sci. (Med.), Professor, Head of the Department of Cardiology and Internal Medicine,</p><p>83, Dzerzhinsky Ave. 83, Minsk 220083.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9822-4357</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чазова</surname><given-names>И. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Chazova</surname><given-names>Irina E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чазова Ирина Евгеньевна (председатель), д.м.н., профессор, академик РАН, заместитель генерального директора по научно-экспертной работе, руководитель отдела гипертонии, Институт клинической кардиологии им. А.Л. Мясникова, </p><p>г. Москва.</p></bio><bio xml:lang="en"><p>Irina E. Chazova, Prof., Dr. of Sci. (Med.), Academician of RAS, Deputy General Director for Scientific and Expert Work, Head of Department of Hypertension, A.L. Myasnikov Research Institute of Cardiology,</p><p>Moscow.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5180-9876</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суджаева</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sudzhaeva</surname><given-names>Olga A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Суджаева Ольга Александровна, д.м.н., доцент, заведующая лабораторией хронической ишемической болезни сердца,</p><p>г. Минск.</p></bio><bio xml:lang="en"><p>Olga A. Sudzhaeva, Dr. of Sci. (Med.), Associate Professor, Head of the Laboratory of Chronic Ischemic Heart Disease,</p><p>Minsk.</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8120-6267</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григоренко</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigorenko</surname><given-names>Elena A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Григоренко Елена Александровна, д.м.н., доцент, профессор кафедры кардиологии и внутренних болезней; главный научный сотрудник лаборатории артериальной гипертензии и профилактической кардиологии,</p><p> пр. Дзержинского, д. 83, г. Минск 220083.</p></bio><bio xml:lang="en"><p>Elena A. Grigorenko, Dr. of Sci. (Med.), Associate Professor, Professor of the Department of Cardiology and Internal Medicine; Chief Researcher of the Laboratory of Arterial Hypertension and Preventive Cardiology,</p><p>Minsk.</p></bio><email xlink:type="simple">alegri@tut.by</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-6954-675X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калачик</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalachik</surname><given-names>Oleg V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Калачик Олег Валентинович, д.м.н., профессор, заместитель директора по медицинской части, руководитель республиканского центра нефрологии, почечно-заместительной терапии и трансплантации почки,</p><p>г. Минск.</p></bio><bio xml:lang="en"><p>Oleg V. Kalachik, Dr. of Sci. (Med.), Professor, Deputy Director for Medical Affairs, Head of the Republican Center for Nephrology, Renal Replacement Therapy and Kidney Transplantation,</p><p>Minsk.</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-3705-1829</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестакова</surname><given-names>Л. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Shestakova</surname><given-names>Liana G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шестакова Лиана Геннадьевна, д.м.н., доцент, заведующая отделением экстракорпорального кровообращения,</p><p>г. Минск.</p></bio><bio xml:lang="en"><p>Liana G. Shestakova, Dr. of Sci. (Med.), Professor, Head of the Extracorporeal Circulation Department,</p><p>Minsk.</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7217-9941</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бранковская</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Brankovskaya</surname><given-names>Elena Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бранковская Елена Юрьевна, к.м.н., врач-кардиолог,</p><p>г. Минск.</p></bio><bio xml:lang="en"><p>Elena Yu. Brankovskaya, Cand. of Sci. (Med.), cardiologist,</p><p>Minsk.</p></bio><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5152-2181</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смолякова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smolyakova</surname><given-names>Maria V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смолякова Мария Васильевна, к.м.н., врач-нефролог отделения нефрологии и гемодиализа,</p><p>г. Минск.</p></bio><bio xml:lang="en"><p>Maria V. Smolyakova, Cand. of Sci. (Med.), nephrologist, Department of Nephrology and Hemodialysis,</p><p>Minsk.</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5820-1759</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трушина</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Trushina</surname><given-names>Olga Iu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Трушина Ольга Юрьевна, д.м.н., профессор кафедры факультетской терапии №1, Институт клинической медицины им. Н.В. Склифосовского,</p><p>ул. Большая Пироговская, д. 6, стр. 1, г. Москва 119435.</p></bio><bio xml:lang="en"><p>Olga Iu. Trushina, Dr. Sci. (Med.), Professor, Chair of Faculty Therapy №1, N.V. Sklifosovsky Institute of Clinical Medicine,</p><p>Bolshaya Pirogovskaya St., 6, building 1, Moscow 119435.</p></bio><email xlink:type="simple">mironova_o_yu@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0758-5609</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Подзолков</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Podzolkov</surname><given-names>Valery I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Подзолков Валерий Иванович, д.м.н., профессор, заведующий кафедрой факультетской терапии № 2 Института клинической медицины им. Н.В. Склифосовского, директор факультетской терапевтической клиники УКБ №4,</p><p>г. Москва.</p></bio><bio xml:lang="en"><p>Valery I. Podzolkov, professor, head of Department of Faculty Therapy No 2, N.V. Sklifosovsky Institute of Clinical Medicine,</p><p>Moscow.</p></bio><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2699-1610</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брагина</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Bragina</surname><given-names>Anna E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Брагина Анна Евгеньевна, д.м.н., профессор кафедры факультетской терапии №2,</p><p>г. Москва.</p></bio><bio xml:lang="en"><p>Anna E. Bragina, Dr. Sci. (Med.), Professor of the Department of Faculty Therapy No 2,</p><p>Moscow.</p></bio><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8007-5680</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бобкова</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Bobkova</surname><given-names>Irina N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бобкова Ирина Николаевна, д.м.н., профессор кафедры внутренних, профессиональных болезней и ревматологии, заведующая отделом нефрологии, Институт клинической медицины им. Н.В. Склифосовского,</p><p>г. Москва.</p></bio><bio xml:lang="en"><p>Irina N. Bobkova, Dr. of Sci. (Med.), Professor of the Departments of Internal, Occupational Diseases and Rheumatology, N.V. Sklifosovsky Institute of Clinical Medicine,</p><p>Moscow.</p></bio><xref ref-type="aff" rid="aff-9"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2028-8748</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кисляк</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kislyak</surname><given-names>Oxana A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кисляк Оксана Андреевна, д.м.н., профессор, профессор кафедры факультетской терапии, </p><p>г. Москва.</p></bio><bio xml:lang="en"><p>Oxana A. Kislyak, Dr. of Sci. (Med.), Professor, Professor of the Department of Faculty Therapy,</p><p>Moscow.</p></bio><xref ref-type="aff" rid="aff-10"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2682-4417</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fomin</surname><given-names>Viktor V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фомин Виктор Викторович, академик РАН, профессор, д.м.н., заведующий кафедрой факультетской терапии №1, Институт клинической медицины им. Н. В. Склифосовского,</p><p>г. Москва.</p></bio><bio xml:lang="en"><p>Viktor V. Fomin, Academician of RAS, Professor, Dr. of Sci. (Med.), Head of the Department of Faculty Therapy No. 1, N.V. Sklifosovsky Institute of Clinical Medicine,</p><p>Moscow.</p></bio><xref ref-type="aff" rid="aff-11"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5215-4894</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блинова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Blinova</surname><given-names>Nataliya V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Блинова Наталия Владимировна (секретарь), к.м.н., старший научный сотрудник отдела гипертонии, НИИ клинической кардиологии им. А.Л. Мясникова, </p><p>г. Москва.</p></bio><bio xml:lang="en"><p>Nataliya V. Blinova, Cand. of Sci. (Med.), Senior Researcher of Department of Hypertension, A.L. Myasnikov Institute of Clinical Cardiology,</p><p>Moscow.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Belarusian State Medical University</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ кардиологии им. акад. Е.И. Чазова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E.I. Chazov National Medical Research Center Of Cardiology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Государственное учреждение «Республиканский научно-практический центр «Кардиология»</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Republican Scientific and Practical Center «Cardiology»</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет; Государственное учреждение «Республиканский научно-практический центр «Кардиология»</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Belarusian State Medical University; Republican Scientific and Practical Center «Cardiology»</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Государственное учреждение «Минский научно-практический центр хирургии, трансплантологии и гематологии»</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>State Institution «Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology»</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Медицинский центр «Маяк Здоровья»</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Medical center «Mayak of Health»</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>ФГАОУ Первый МГМУ им. И.М. Сеченова (Сеченовский Университет) Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-8"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-9"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-10"><aff xml:lang="ru"><institution>ФГАОУ ВО РНИМУ им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-11"><aff xml:lang="ru"><institution>Первый МГМУ им. И. М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>28</day><month>05</month><year>2026</year></pub-date><volume>0</volume><issue>2</issue><fpage>6</fpage><lpage>41</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Митьковская Н.П., Чазова И.Е., Суджаева О.А., Григоренко Е.А., Калачик О.В., Шестакова Л.Г., Бранковская Е.Ю., Смолякова М.В., Трушина О.Ю., Подзолков В.И., Брагина А.Е., Бобкова И.Н., Кисляк О.А., Фомин В.В., Блинова Н.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Митьковская Н.П., Чазова И.Е., Суджаева О.А., Григоренко Е.А., Калачик О.В., Шестакова Л.Г., Бранковская Е.Ю., Смолякова М.В., Трушина О.Ю., Подзолков В.И., Брагина А.Е., Бобкова И.Н., Кисляк О.А., Фомин В.В., Блинова Н.В.</copyright-holder><copyright-holder xml:lang="en">Mitkovskaya N.P., Chazova I.E., Sudzhaeva O.A., Grigorenko E.A., Kalachik O.V., Shestakova L.G., Brankovskaya E.Y., Smolyakova M.V., Trushina O.I., Podzolkov V.I., Bragina A.E., Bobkova I.N., Kislyak O.A., Fomin V.V., Blinova N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.heartj.asia/jour/article/view/6599">https://www.heartj.asia/jour/article/view/6599</self-uri><abstract><p>Кардиоренальный синдром (КРС) охватывает спектр расстройств, затрагивающих как сердце, так и почки, при которых острая или хроническая дисфункция в одном органе может вызвать острую или хроническую дисфункцию в другом органе. Концепция КРС упорядочила многочисленные взаимосвязи между острым и хроническим повреждением сердца и почек и объединила кардиологов и нефрологов в борьбе за качество и продолжительность жизни пациентов. Выявление вовлечения в патологический процесс почек на ранних стадиях сердечно-сосудистого континуума, начиная с факторов риска, позволит проводить профилактические мероприятия, что будет способствовать улучшению как сердечно-сосудистых, так и почечных исходов. Вышеизложенное обусловило подготовку настоящих рекомендаций. Рекомендации включают современные подходы к диагностике, лечению и профилактике всех 5 типов КРС при различных сердечно-сосудистых заболеваниях. В рекомендациях кратко представлены основные патофизиологические механизмы развития КРС и современные классификации. Подробно освещены крайне актуальные и на наш взгляд недостаточно освещенные вопросы диагностики и лечения контраст-индуцированной нефропатии, заместительной почечной терапии и ее место в лечении КРС, что на наш взгляд сделает рекомендации интересными и полезными для широкого круга врачей-специалистов. Рекомендации предназначены не только для врачей-кардиологов, нефрологов, кардиохирургов, рентгенэндоваскулярных хирургов, анестезиологов-реаниматологов и перфузиологов, но и для врачей общей практики и врачей-терапевтов, которые стоят на первой линии борьбы с КРС. Примечательно, что при подготовке рекомендаций использован собственный опыт работы Государственного учреждения «Республиканский научно-практический центр «Кардиология» и Государственного учреждения «Минский научно-практический центр хирургии трансплантации и гематологии» (Минск, Республика Беларусь).</p></abstract><trans-abstract xml:lang="en"><p>Cardiorenal syndrome (CRS) covers a spectrum of disorders affecting both the heart and kidneys, in which acute or chronic dysfunction in one organ can cause acute or chronic dysfunction in another organ. The concept of CRS has streamlined the numerous relationships between acute and chronic heart and kidney diseases and united cardiologists and nephrologists in the struggle for the quality and life expectancy of patients. Identification of kidney involvement in the pathological process at the early stages of the cardiovascular continuum, starting with risk factors, will allow for preventive measures that will help improve both cardiovascular and renal outcomes. The above has led to the preparation of these recommendations. The recommendations include modern approaches to the diagnosis, treatment and prevention of all 5 types of CRS in various cardiovascular diseases. The recommendations briefly present the main pathophysiological mechanisms of cattle development and modern classifications. The extremely relevant and, in our opinion, insufficiently covered issues of diagnosis and treatment of contrast-induced nephropathy, renal replacement therapy and its place in the treatment of cattle are highlighted in detail, which, in our opinion, will make the recommendations interesting and useful for a wide range of specialist doctors. The recommendations are intended not only for cardiologists, nephrologists, cardiac and endovascular surgeons, anesthesiologists, intensive care physicians and perfusiologists, but also for general practitioners and internists who are on the first line of the fight against CRS. It is noteworthy that when preparing the recommendations, we used our own experience of the State Institution «Republican Scientific and Practical Center of Cardiology» and the State Institution «Minsk Scientific and Practical Center for Transplant Surgery and Hematology» (Minsk, Republic of Belarus).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сердечно-сосудистые заболевания</kwd><kwd>кардиоренальный синдром</kwd><kwd>острое повреждение почек</kwd><kwd>сахарный диабет</kwd><kwd>биомаркеры</kwd><kwd>хроническая болезнь почек</kwd><kwd>диализ</kwd><kwd>диуретики</kwd><kwd>сердечная недостаточность</kwd><kwd>госпитализация</kwd><kwd>трансплантация почки</kwd><kwd>ультрафильтрация</kwd><kwd>летальность</kwd><kwd>клинические рекомендации</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cardiovascular disease</kwd><kwd>cardiorenal syndrome</kwd><kwd>diabetes mellitus</kwd><kwd>acute kidney injury</kwd><kwd>biomarkers</kwd><kwd>chronic kidney disease</kwd><kwd>dialysis</kwd><kwd>diuretics</kwd><kwd>heart failure</kwd><kwd>hospitalization</kwd><kwd>kidney transplantation</kwd><kwd>mortality</kwd><kwd>ultrafiltration</kwd><kwd>clinical guidelines</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dzau V, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J. 1991 Apr;121(4 Pt 1):1244-63. https://doi.org/10.1016/0002-8703(91)90694-d</mixed-citation><mixed-citation xml:lang="en">Dzau V, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J. 1991 Apr;121(4 Pt 1):1244-63. https://doi.org/10.1016/0002-8703(91)90694-d</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dzau V. The cardiovascular continuum and renin-angiotensinaldosterone system blockade. J Hypertens Suppl. 2005 Apr;23(1):S9-17. PMID: 15821452.</mixed-citation><mixed-citation xml:lang="en">Dzau V. The cardiovascular continuum and renin-angiotensinaldosterone system blockade. J Hypertens Suppl. 2005 Apr;23(1):S9-17. PMID: 15821452.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">LEDOUX P. Les cardio-rénaux [Cardiorenal syndrome]. Avenir Med. 1951 Oct;48(8):149-53. Undetermined Language. PMID: 14878683.</mixed-citation><mixed-citation xml:lang="en">LEDOUX P. Les cardio-rénaux [Cardiorenal syndrome]. Avenir Med. 1951 Oct;48(8):149-53. Undetermined Language. PMID: 14878683.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Silverberg D. Outcomes of anaemia management in renal insufficiency and cardiac disease. Nephrol Dial Transplant. 2003 Jun;18 Suppl 2:ii7-12. PMID: 12819294.</mixed-citation><mixed-citation xml:lang="en">Silverberg D. Outcomes of anaemia management in renal insufficiency and cardiac disease. Nephrol Dial Transplant. 2003 Jun;18 Suppl 2:ii7-12. PMID: 12819294.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C. Cardiorenal and renocardiac syndromes: clinical disorders in search of a systematic definition. Int J Artif Organs. 2008 Jan;31(1):1-2. https://doi.org/10.1177/039139880803100101</mixed-citation><mixed-citation xml:lang="en">Ronco C. Cardiorenal and renocardiac syndromes: clinical disorders in search of a systematic definition. Int J Artif Organs. 2008 Jan;31(1):1-2. https://doi.org/10.1177/039139880803100101</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39. https://doi.org/10.1016/j.jacc.2008.07.051</mixed-citation><mixed-citation xml:lang="en">Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39. https://doi.org/10.1016/j.jacc.2008.07.051</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA. Cardiac and Vascular SurgeryAssociated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018 Jun 1;7(11):e008834. PMID: 29858368; PMCID: PMC6015369. https://doi.org/10.1161/JAHA.118.008834</mixed-citation><mixed-citation xml:lang="en">Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA. Cardiac and Vascular SurgeryAssociated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018 Jun 1;7(11):e008834. PMID: 29858368; PMCID: PMC6015369. https://doi.org/10.1161/JAHA.118.008834</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Birnie K, Verheyden V, Pagano D, Bhabra M, Tilling K, Sterne JA, Murphy GJ; UK AKI in Cardiac Surgery Collaborators. Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care. 2014 Nov 20;18(6):606. https://doi.org/10.1186/s13054-014-0606-x</mixed-citation><mixed-citation xml:lang="en">Birnie K, Verheyden V, Pagano D, Bhabra M, Tilling K, Sterne JA, Murphy GJ; UK AKI in Cardiac Surgery Collaborators. Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care. 2014 Nov 20;18(6):606. https://doi.org/10.1186/s13054-014-0606-x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J. Preoperative renal risk stratification. Circulation. 1997 Feb 18;95(4):878-84. https://doi.org/10.1161/01.cir.95.4.878</mixed-citation><mixed-citation xml:lang="en">Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J. Preoperative renal risk stratification. Circulation. 1997 Feb 18;95(4):878-84. https://doi.org/10.1161/01.cir.95.4.878</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Palomba H, de Castro I, Neto ALC, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney International. 2007;72(5):624-631. https://doi.org/10.1038/sj.ki.5002419</mixed-citation><mixed-citation xml:lang="en">Palomba H, de Castro I, Neto ALC, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney International. 2007;72(5):624-631. https://doi.org/10.1038/sj.ki.5002419</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jorge-Monjas P, Bustamante-Munguira J, Lorenzo M, HerediaRodríguez M, Fierro I, Gómez-Sánchez E, Hernandez A, Álvarez FJ, Bermejo-Martin JF, Gómez-Pesquera E, Gómez-Herreras JI, Tamayo E. Predicting cardiac surgery-associated acute kidney injury: The CRATE score. J Crit Care. 2016 Feb;31(1):130-8. https://doi.org/10.1016/j.jcrc.2015.11.004</mixed-citation><mixed-citation xml:lang="en">Jorge-Monjas P, Bustamante-Munguira J, Lorenzo M, HerediaRodríguez M, Fierro I, Gómez-Sánchez E, Hernandez A, Álvarez FJ, Bermejo-Martin JF, Gómez-Pesquera E, Gómez-Herreras JI, Tamayo E. Predicting cardiac surgery-associated acute kidney injury: The CRATE score. J Crit Care. 2016 Feb;31(1):130-8. https://doi.org/10.1016/j.jcrc.2015.11.004</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pannu N, Graham M, Klarenbach S, et al. A new model to predict acute kidney injury requiring renal replacement therapy after cardiac surgery. CMAJ 2016;188:1076-1083. https://doi.org/10.1503/cmaj.151447</mixed-citation><mixed-citation xml:lang="en">Pannu N, Graham M, Klarenbach S, et al. A new model to predict acute kidney injury requiring renal replacement therapy after cardiac surgery. CMAJ 2016;188:1076-1083. https://doi.org/10.1503/cmaj.151447</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009 Jun 23;119(24):3053-61. https://doi.org/10.1161/circulationaha.108.842393</mixed-citation><mixed-citation xml:lang="en">Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009 Jun 23;119(24):3053-61. https://doi.org/10.1161/circulationaha.108.842393</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005 Jan;16(1):162-8. https://doi.org/10.1681/asn.2004040331</mixed-citation><mixed-citation xml:lang="en">Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005 Jan;16(1):162-8. https://doi.org/10.1681/asn.2004040331</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Резник Е.В., Никитин И.Г. Кардиоренальный синдром у больных с сердечной недостаточностью как этап кардиоренального континуума (часть I): определение, классификация, патогенез, диагностика, эпидемиология (обзор литературы). Архивъ внутренней медицины. 2019;9(1):5-22. https://doi.org/10.20514/2226-6704-2019-9-1-5-22</mixed-citation><mixed-citation xml:lang="en">Reznik E.V., Nikitin I.G. Cardiorenal syndrome in patients with chronic heart failure as a stage of the cardiorenal continuum (part i): definition, classification, pathogenesis, diagnosis, epidemiology. The Russian Archives of Internal Medicine. 2019;9(1):5-22. (In Russ.) https://doi.org/10.20514/2226-6704-2019-9-1-5-22</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mullens W, Damman K, Testani JM, Martens P, Mueller C, Lassus J, Tang WHW, Skouri H, Verbrugge FH, Orso F, Hill L, Ural D, Lainscak M, Rossignol P, Metra M, Mebazaa A, Seferovic P, Ruschitzka F, Coats A. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Apr;22(4):584-603. https://doi.org/10.1002/ejhf.1697</mixed-citation><mixed-citation xml:lang="en">Mullens W, Damman K, Testani JM, Martens P, Mueller C, Lassus J, Tang WHW, Skouri H, Verbrugge FH, Orso F, Hill L, Ural D, Lainscak M, Rossignol P, Metra M, Mebazaa A, Seferovic P, Ruschitzka F, Coats A. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Apr;22(4):584-603. https://doi.org/10.1002/ejhf.1697</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Трушина ОЮ. Кардио-рено-метаболический синдром: междисциплинарный подход. Терапевтический архив 2025;97(9):789- 792. https://doi.org/10.26442/00403660.2025.09.203346</mixed-citation><mixed-citation xml:lang="en">Trushina OI. Cardiovascular-kidney-metabolic syndrome: the interdisciplinary approach. A review. Terapevticheskii arkhiv 2025;97(9):789-792. (In Russ.) https://doi.org/10.26442/00403660.2025.09.203346</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Окишева ЕА, Трушина ОЮ. Биомаркеры острого коронарного синдрома: от истоков до наших дней. Терапевтический архив 2024;96(9):914-918. https://doi.org/10.26442/00403660.2024.09.202854</mixed-citation><mixed-citation xml:lang="en">Okisheva EA, Trushina OI. Biomarkers in acute coronary syndromes: from the origins to the present. Terapevticheskii arkhiv 2024;96(9):914-918. (In Russ.) https://doi.org/10.26442/00403660.2024.09.202854</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Srisawat N, Kellum JA. The Role of Biomarkers in Acute Kidney Injury. Crit Care Clin. 2020 Jan;36(1):125-140. https://doi.org/10.1016/j.ccc.2019.08.010</mixed-citation><mixed-citation xml:lang="en">Srisawat N, Kellum JA. The Role of Biomarkers in Acute Kidney Injury. Crit Care Clin. 2020 Jan;36(1):125-140. https://doi.org/10.1016/j.ccc.2019.08.010</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Stevens, Jacob S., and Jai Radhakrishnan. "Kidney replacement therapy for patients requiring cardiopulmonary bypass support during cardiac surgery." Clinical Journal of the American Society of Nephrology. 2021 Dec;16(12):1898-1900. https://doi.org/10.2215/cjn.07150521</mixed-citation><mixed-citation xml:lang="en">Stevens, Jacob S., and Jai Radhakrishnan. "Kidney replacement therapy for patients requiring cardiopulmonary bypass support during cardiac surgery." Clinical Journal of the American Society of Nephrology. 2021 Dec;16(12):1898-1900. https://doi.org/10.2215/cjn.07150521</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Щелкановцева Е.С., Миронова О.Ю., Фомин В.В. Маркеры острого повреждения почек. Перспективы их применения в практической деятельности. Consilium Medicum. 2021;23(1):15- 19. https://doi.org/10.26442/20751753.2021.1.200729</mixed-citation><mixed-citation xml:lang="en">Schelkanovtseva ES, Mironova OIu, Fomin VV. Biomarkers of acute kidney disease. Potential application in practice. Consilium Medicum. 2021; 23(1):15–19. (In Russ.) https://doi.org/10.26442/20751753.2021.1.200729</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Чихладзе Н.М., Блинова Н.В., Аксенова А.В., Алексеева Т.А., Амбатьелло Л.Г., Баланова Ю.А., Брагина А.Е., Данилов Н.М., Драпкина О.М., Дроздова Л.Ю., Ежов М.В., Елфимова Е.М., Жернакова Ю.В., Жиров И.В., Кисляк О.А., Литвин А.Ю., Небиеридзе Д.В., Остроумова О.Д., Подзолков В.И., Сергиенко И.В., Сивакова О.А., Стародубова А.В., Стрюк Р.И., Терещенко С.Н., Трушина О.Ю., Щелкова Г.В. Клинические рекомендации Российского медицинского общества по артериальной гипертонии (РМОАГ) и Евразийской Ассоциации Кардиологов (ЕАК) по диагностике и лечению артериальной гипертонии (2024). Системные гипертензии. 25 декабря 2024;21(4):5-109. https://doi.org/10.38109/2075-082X-2024-4-5-109</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Chikhladze N.M., Blinova N.V., Aksenova A.V., Alekseeva T.A., Ambatiello L.G., Balanova Yu.A., Bragina A.E., Danilov N.M., Drapkina O.M., Drozdova L.Yu., Ezhov M.V., Elfimova E.M., Zhernakova Yu.V., Zhirov I.V., Kislyak O.A., Litvin A.Yu., Nebieridze D.V., Ostroumova O.D., Podzolkov V.I., Sergienko I.V., Sivakova O.A., Starodubova A.V., Stryuk R.I., Tereshchenko S.N., Trushina O.Yu., Shchelkova G.V. Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024). Systemic Hypertension. 2024;21(4):5- 110. (In Russ.) https://doi.org/10.38109/2075-082X-2024-4-5-109</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Солнцева Т.Д., Сивакова О.А., Агеев Ф.Т., Фофанова Т.В., Брагина А.Е., Трушина О.Ю. Консенсус экспертов Российского медицинского общества по артериальной гипертонии. Артериальная гипертония и приверженность к антигипертензивной терапии. Системные гипертензии. 2024;21(2):5-15. https://doi.org/10.38109/2075-082X-2024-2-5-15</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Solntseva T.D., Sivakova O.A., Ageev F.T., Fofanova T.V., Bragina A.E., Trushina O.I. Russian Medical Society for Arterial Hypertension expert consensus. Arterial hypertension and adherence to antihypertensive therapy. Systemic Hypertension. 2024;21(2):7-17. (In Russ.) https://doi.org/10.38109/2075-082X-2024-2-5-15</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">McDonagh Т.А., Metra Ь., Adamo M., Gardner R.S. et al. ESC Scientific Document Group, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages 3599–3726, https://doi.org/10.1093/eurheartj/ehab368</mixed-citation><mixed-citation xml:lang="en">McDonagh Т.А., Metra Ь., Adamo M., Gardner R.S. et al. ESC Scientific Document Group, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages 3599–3726, https://doi.org/10.1093/eurheartj/ehab368</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müller GA, Birkhahn R, Clopton P, Taub P, Vilke GM, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT. Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study. J Am Coll Cardiol. 2016 Sep 27;68(13):1420-1431. https://doi.org/10.1016/j.jacc.2016.06.055</mixed-citation><mixed-citation xml:lang="en">Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müller GA, Birkhahn R, Clopton P, Taub P, Vilke GM, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT. Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study. J Am Coll Cardiol. 2016 Sep 27;68(13):1420-1431. https://doi.org/10.1016/j.jacc.2016.06.055</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. https://doi.org/10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019 Feb 1;40(5):475. https://doi.org/10.1093/eurheartj/ehy686</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. https://doi.org/10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019 Feb 1;40(5):475. https://doi.org/10.1093/eurheartj/ehy686</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации Хроническая болезнь почек (ХБП) 2021. Разработчик клинической рекомендации: Ассоциация нефрологов. Нефрология. 2021;25(5):10-82.</mixed-citation><mixed-citation xml:lang="en">Clinical recommendations. Chronic kidney disease (CKD). Developer of the clinical recommendation: Association of Nephrologists. Nephrology (Saint-Petersburg). 2021;25(5):10-82. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987 Jun 4;316(23):1429-1435. https://doi.org/10.1056/NEJM198706043162301</mixed-citation><mixed-citation xml:lang="en">CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987 Jun 4;316(23):1429-1435. https://doi.org/10.1056/NEJM198706043162301</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">SOLVD Investigators; Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):293-302. https://doi.org/10.1056/nejm199108013250501</mixed-citation><mixed-citation xml:lang="en">SOLVD Investigators; Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):293-302. https://doi.org/10.1056/nejm199108013250501</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. Angiotensinneprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 Sep 11;371(11):993-1004. https://doi.org/10.1056/nejmoa1409077</mixed-citation><mixed-citation xml:lang="en">McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. Angiotensinneprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 Sep 11;371(11):993-1004. https://doi.org/10.1056/nejmoa1409077</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ; Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet. 2012 Oct 20;380(9851):1387-95. https://doi.org/10.1016/s0140-6736(12)61227-6</mixed-citation><mixed-citation xml:lang="en">Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ; Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet. 2012 Oct 20;380(9851):1387-95. https://doi.org/10.1016/s0140-6736(12)61227-6</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999 Sep 2;341(10):709-17. https://doi.org/10.1056/nejm199909023411001</mixed-citation><mixed-citation xml:lang="en">Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999 Sep 2;341(10):709-17. https://doi.org/10.1056/nejm199909023411001</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenzweig JL, Bakris GL, Berglund LF, et al. Primary prevention of ASCVD and T2DM in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2019;104:3939- 3985. https://doi.org/10.1210/jc.2019-01338</mixed-citation><mixed-citation xml:lang="en">Rosenzweig JL, Bakris GL, Berglund LF, et al. Primary prevention of ASCVD and T2DM in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2019;104:3939- 3985. https://doi.org/10.1210/jc.2019-01338</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Шестакова М.В., Жернакова Ю.В. и соавт. Евразийские рекомендации по профилактике и лечению сердечно-сосудистых заболеваний у больных с диабетом и предиабетом (2021). Евразийский Кардиологический Журнал. 2021;(2):6-61. https://doi.org/10.38109/2225-1685-2021-2-6-61</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Shestakova M.V., Zhernakova Yu.V., et al. Eurasian association of cardiology (eac) guidelines for the prevention and treatment of cardiovascular diseases in patients with diabetes and prediabetes (2021). Eurasian heart journal. 2021;(2):6-61. (In Russ.) https://doi.org/10.38109/2225-1685-2021-2-6-61</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Chen HH, Anstrom KJ, Givertz MM, et al. Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial. JAMA. 2013;310(23):2533-2543. https://doi.org/10.1001/jama.2013.282190</mixed-citation><mixed-citation xml:lang="en">Chen HH, Anstrom KJ, Givertz MM, et al. Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial. JAMA. 2013;310(23):2533-2543. https://doi.org/10.1001/jama.2013.282190</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E; PIONEER-HF Investigators. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019 Feb 7;380(6):539-548. https://doi.org/10.1056/NEJMoa1812851</mixed-citation><mixed-citation xml:lang="en">Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E; PIONEER-HF Investigators. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019 Feb 7;380(6):539-548. https://doi.org/10.1056/NEJMoa1812851</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Bradley A. Bart, M.D., Steven R. Goldsmith, M.D., Kerry L. Lee, Ph.D., Michael M. Givertz, M.D., Christopher M. O'Connor, M.D., David A. Bull, M.D., Margaret M. Redfield, M.D., Anita Deswal, M.D., M.P.H., Jean L. Rouleau, M.D., Martin M. LeWinter, M.D., Elizabeth O. Ofili, M.D., M.P.H., Lynne W. Stevenson, M.D., et al., for the Heart Failure Clinical Research Network Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome/ December 13, 2012 N Engl J Med 2012;367:2296-2304. https://doi.org/10.1056/NEJMoa1210357</mixed-citation><mixed-citation xml:lang="en">Bradley A. Bart, M.D., Steven R. Goldsmith, M.D., Kerry L. Lee, Ph.D., Michael M. Givertz, M.D., Christopher M. O'Connor, M.D., David A. Bull, M.D., Margaret M. Redfield, M.D., Anita Deswal, M.D., M.P.H., Jean L. Rouleau, M.D., Martin M. LeWinter, M.D., Elizabeth O. Ofili, M.D., M.P.H., Lynne W. Stevenson, M.D., et al., for the Heart Failure Clinical Research Network Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome/ December 13, 2012 N Engl J Med 2012;367:2296-2304. https://doi.org/10.1056/NEJMoa1210357</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct 4;372(9645):1223-30. Epub 2008 Aug 29. PMID: 18757090. https://doi.org/10.1016/S0140-6736(08)61239-8</mixed-citation><mixed-citation xml:lang="en">Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct 4;372(9645):1223-30. Epub 2008 Aug 29. PMID: 18757090. https://doi.org/10.1016/S0140-6736(08)61239-8</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Жернакова Ю.В., Блинова Н.В., Маркова Т.Н., Мазурина Н.В., Жиров И.В., Ускач Т.М., Сафиуллина А.А., Миронова О.Ю., Елфимова Е.М., Литвин А.Ю., Железнова Е.А., Юричева Ю.А. Евразийские рекомендации по профилактике и лечению сердечно-сосудистых заболеваний у больных с ожирением (2022). Евразийский кардиологический журнал. 2022;(3):6-56. https://doi.org/10.38109/2225-1685-2022-3-6-56</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Zhernakova Yu.V., Blinova N.V., Markova T.N., Mazurina N.V., Zhirov I.V., Uskach T.M., Safiullina A.A., Mironova O.I., Elfimova E.M., Litvin A.Yu., Zheleznova E.A., Yuricheva Yu.A., Azizov V.A., Grigorenko E.A., Rahimov Z.Ya., Kasymova S.D., Mustafaev I.I., Narzullaeva A.R., Polupanov A.G., Sarybaev A.Sh., Srozhidinova N.Z. Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022). Eurasian heart journal. 2022;(3):6-56. (In Russ.) https://doi.org/10.38109/2225-1685-2022-3-6-56</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371(7):624–34. https://doi.org/10.1056/nejmoa1304127</mixed-citation><mixed-citation xml:lang="en">Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371(7):624–34. https://doi.org/10.1056/nejmoa1304127</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol.2019;74(14):1823–38. https://doi.org/10.1016/j.jacc.2019.08.1017</mixed-citation><mixed-citation xml:lang="en">Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol.2019;74(14):1823–38. https://doi.org/10.1016/j.jacc.2019.08.1017</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC, et al. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2016;90(6):1175- 1183. https://doi.org/10.1016/j.kint.2016.09.010</mixed-citation><mixed-citation xml:lang="en">Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC, et al. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2016;90(6):1175- 1183. https://doi.org/10.1016/j.kint.2016.09.010</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. https://doi.org/10.1016/j.kint.2023.10.018</mixed-citation><mixed-citation xml:lang="en">Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. https://doi.org/10.1016/j.kint.2023.10.018</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Gæde P, Oellgaard J, Carstensen B, Rossing P, Lund-Andersen H, Parving HH, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia [Internet]. 2016;59(11):2298–2307. https://doi.org/10.1007/s00125-016-4065-6</mixed-citation><mixed-citation xml:lang="en">Gæde P, Oellgaard J, Carstensen B, Rossing P, Lund-Andersen H, Parving HH, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia [Internet]. 2016;59(11):2298–2307. https://doi.org/10.1007/s00125-016-4065-6</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Parving H-H, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P. The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes. N Engl J Med [Internet]. 2001 Sep 20;345(12):870–8. Available from: https://doi.org/10.1056/NEJMoa011489</mixed-citation><mixed-citation xml:lang="en">Parving H-H, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P. The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes. N Engl J Med [Internet]. 2001 Sep 20;345(12):870–8. Available from: https://doi.org/10.1056/NEJMoa011489</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S; INNOVATION Study Group. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care. 2007 Jun;30(6):1577-1578. https://doi.org/10.2337/dc06-1998</mixed-citation><mixed-citation xml:lang="en">Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S; INNOVATION Study Group. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care. 2007 Jun;30(6):1577-1578. https://doi.org/10.2337/dc06-1998</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-H, et al. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med [Internet]. 2001 Sep 20;345(12):861–9. https://doi.org/10.1056/NEJMoa011161</mixed-citation><mixed-citation xml:lang="en">Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-H, et al. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med [Internet]. 2001 Sep 20;345(12):861–9. https://doi.org/10.1056/NEJMoa011161</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006257. https://doi.org/10.1002/14651858.cd006257</mixed-citation><mixed-citation xml:lang="en">Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006257. https://doi.org/10.1002/14651858.cd006257</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitorassociated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000 Mar 13;160(5):685-93. https://doi.org/10.1001/archinte.160.5.685</mixed-citation><mixed-citation xml:lang="en">Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitorassociated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000 Mar 13;160(5):685-93. https://doi.org/10.1001/archinte.160.5.685</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GFM. Aldosterone antagonists for preventing the progression of chronic kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4(3):542–51. https://doi.org/10.2215/cjn.04750908</mixed-citation><mixed-citation xml:lang="en">Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GFM. Aldosterone antagonists for preventing the progression of chronic kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4(3):542–51. https://doi.org/10.2215/cjn.04750908</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, et al. Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. Am J Nephrol. 2019;50(5):333–44. https://doi.org/10.1159/000503713</mixed-citation><mixed-citation xml:lang="en">Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, et al. Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. Am J Nephrol. 2019;50(5):333–44. https://doi.org/10.1159/000503713</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Wong MG, Perkovic V, Chalmers J, Woodward M, Li Q, Cooper ME, et al. Long-term benefits of intensive glucose Control for preventing end-stage kidney disease: ADVANCE-ON. Diabetes Care.2016;39(5):694–700. https://doi.org/10.2337/dc15-2322</mixed-citation><mixed-citation xml:lang="en">Wong MG, Perkovic V, Chalmers J, Woodward M, Li Q, Cooper ME, et al. Long-term benefits of intensive glucose Control for preventing end-stage kidney disease: ADVANCE-ON. Diabetes Care.2016;39(5):694–700. https://doi.org/10.2337/dc15-2322</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Roussel R, Lorraine J, Rodriguez A, Salaun-Martin C. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease. Adv Ther.2015;32(11):1029-64. https://doi.org/10.1007/s12325-015-0261-x</mixed-citation><mixed-citation xml:lang="en">Roussel R, Lorraine J, Rodriguez A, Salaun-Martin C. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease. Adv Ther.2015;32(11):1029-64. https://doi.org/10.1007/s12325-015-0261-x</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Turner R. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65. PMID: 9742977.</mixed-citation><mixed-citation xml:lang="en">Turner R. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65. PMID: 9742977.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Crowley MJ, Diamantidis CJ, McDuffie JR, Cameron CB, Stanifer JW, Mock CK, et al. Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: A systematic review. Ann Intern Med. 2017;166(3):191–200. https://doi.org/10.7326/m16-1901</mixed-citation><mixed-citation xml:lang="en">Crowley MJ, Diamantidis CJ, McDuffie JR, Cameron CB, Stanifer JW, Mock CK, et al. Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: A systematic review. Ann Intern Med. 2017;166(3):191–200. https://doi.org/10.7326/m16-1901</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, et al. The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics. Am J Nephrol. 2018;46(6):462–72. https://doi.org/10.1159/000484633</mixed-citation><mixed-citation xml:lang="en">Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, et al. The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics. Am J Nephrol. 2018;46(6):462–72. https://doi.org/10.1159/000484633</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes : A systematic review and meta-analysis. JAMA – J Am Med Assoc. 2015;313(6):603-15. https://doi.org/10.1001/jama.2014.18574</mixed-citation><mixed-citation xml:lang="en">Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes : A systematic review and meta-analysis. JAMA – J Am Med Assoc. 2015;313(6):603-15. https://doi.org/10.1001/jama.2014.18574</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Biostat M, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014;371(15):1392–406. https://doi.org/10.1056/nejmoa1407963</mixed-citation><mixed-citation xml:lang="en">Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Biostat M, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014;371(15):1392–406. https://doi.org/10.1056/nejmoa1407963</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Трушина О.Ю., Окишева Е. А., Солонина А.Д. и др. Анализ функции почек у пациентов после планового ортопедического вмешательства на суставах нижних конечностей в условиях реальной клинической практики. Consilium Medicum. 2025;27(10):609-613. EDN VZBYYU. https://doi.org/10.26442/20751753.2025.10.203438</mixed-citation><mixed-citation xml:lang="en">Trushina OY, Okisheva EА, Solonina AD, Sorokina SA, Panferov AS, Elizarov MP, Lychagin AV, Fomin VV. Analysis of renal function in patients after scheduled orthopedic intervention on lower limb joints in real clinical practice. Consilium Medicum 2025;27(10):609-613. (In Russ.) https://doi.org/10.26442/20751753.2025.10.203438</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Weber MA, Bakris GL, Jamerson K, Weir M, Kjeldsen SE, Devereux RB, et al. Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes. JAC [Internet]. 2010;56(1):77- 85. Available from: https://doi.org/10.1016/j.jacc.2010.02.046</mixed-citation><mixed-citation xml:lang="en">Weber MA, Bakris GL, Jamerson K, Weir M, Kjeldsen SE, Devereux RB, et al. Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes. JAC [Internet]. 2010;56(1):77- 85. Available from: https://doi.org/10.1016/j.jacc.2010.02.046</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Fitchett D, Bluhmki E, Ph D, Hantel S, Ph D, Mattheus M, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. 2015;2117–28. https://doi.org/10.1056/nejmoa1504720</mixed-citation><mixed-citation xml:lang="en">Fitchett D, Bluhmki E, Ph D, Hantel S, Ph D, Mattheus M, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. 2015;2117–28. https://doi.org/10.1056/nejmoa1504720</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">W. MK, Bruce N, Vlado P, Dick de Z, Greg F, Ngozi E, et al. Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events. Circulation [Internet]. 2018 Jan 23;137(4):323-34. https://doi.org/10.1161/CIRCULATIONAHA.117.032038</mixed-citation><mixed-citation xml:lang="en">W. MK, Bruce N, Vlado P, Dick de Z, Greg F, Ngozi E, et al. Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events. Circulation [Internet]. 2018 Jan 23;137(4):323-34. https://doi.org/10.1161/CIRCULATIONAHA.117.032038</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med [Internet]. 2018 Nov 10;380(4):347-57. https://doi.org/10.1056/NEJMoa1812389</mixed-citation><mixed-citation xml:lang="en">Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med [Internet]. 2018 Nov 10;380(4):347-57. https://doi.org/10.1056/NEJMoa1812389</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med [Internet]. 2016 Jun 13;375(4):311-22. https://doi.org/10.1056/NEJMoa1603827</mixed-citation><mixed-citation xml:lang="en">Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med [Internet]. 2016 Jun 13;375(4):311-22. https://doi.org/10.1056/NEJMoa1603827</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med [Internet]. 2016 Sep15;375(19):1834–44. https://doi.org/10.1056/NEJMoa1607141</mixed-citation><mixed-citation xml:lang="en">Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med [Internet]. 2016 Sep15;375(19):1834–44. https://doi.org/10.1056/NEJMoa1607141</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Миронова О.Ю., Исаев Г.О., Бердышева М.В., Шахнович Р.М., Фомин В.В. Современные методики оценки физиологической значимости стенозирующих поражений коронарных артерий. Терапевтический архив. 2023;95(4):341-346. https://doi.org/10.26442/00403660.2023.04.202169</mixed-citation><mixed-citation xml:lang="en">Mironova OI, Isaev GO, Berdysheva MV, Shakhnovich RM, Fomin VV. Modern methods of assessment of physiological significance of coronary lesions: A review. Terapevticheskii arkhiv 2023;95(4):341- 346. (In Russ.) https://doi.org/10.26442/00403660.2023.04.202169</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Окишева Е.А., Миронова О.Ю., Бердышева М.В., Пятигорец Е.С., Кривова Н.П., Курносова А.А., Елизаров М.П., Сметанин С.М., Лычагин А.В., Фомин В.В. Влияние выраженности болевого синдрома и приема нестероидных противовоспалительных препаратов на артериальное давление при плановом эндопротезировании крупных суставов нижних конечностей. Терапевтический архив. 2023;95(9):751–756. https://doi.org/10.26442/00403660.2023.09.202373</mixed-citation><mixed-citation xml:lang="en">Okisheva EA, Mironova OI, Berdysheva MV, Pyatigorets ES, Krivova NP, Kurnosova AA, Elizarov MP, Smetanin SM, Lychagin AV, Fomin VV. Relationship between the pain severity, use of nonsteroidal anti-inflammatory drugs and blood pressure in elective large joint arthroplasty of the lower extremities. Terapevticheskii arkhiv 2023;95(9):751-756. (In Russ.) https://doi.org/10.26442/00403660.2023.09.202373</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Дмитриева О.А., Миронова О.Ю., Сивакова О.А., Денисова А.Р., Солнцева Т.Д., Фомин В.В. Перипроцедурный инфаркт миокарда и вероятность развития контраст-индуцированного острого повреждения почек в клинической практике. Клиническое наблюдение. Терапевтический архив. 2021;93(4):482–486. https://doi.org/10.26442/00403660.2021.04.200686</mixed-citation><mixed-citation xml:lang="en">Dmitrieva OA, Mironova OY, Sivakova OA, Denisova AR, Solnceva TD, Fomin VV. The periprocedural myocardial infarction and probability of the developing of the contrast-induced acute kidneys injury in clinical practice. Case report. Terapevticheskii arkhiv 2021;93(4):482-486. (In Russ.) https://doi.org/10.26442/00403660.2021.04.200686</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Husain-Syed F., Gröne H.J., Assmus B. et al. Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives. ESC Heart Fail 2021;8:183-203. https://doi.org/10.1002/ehf2.13118</mixed-citation><mixed-citation xml:lang="en">Husain-Syed F., Gröne H.J., Assmus B. et al. Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives. ESC Heart Fail 2021;8:183-203. https://doi.org/10.1002/ehf2.13118</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Tabucanon T, Tang WH. Right heart failure and cardiorenal syndrome. Cardiol Clin 2020;38:185-202. https://doi.org/10.1016/j.ccl.2020.01.004</mixed-citation><mixed-citation xml:lang="en">Tabucanon T, Tang WH. Right heart failure and cardiorenal syndrome. Cardiol Clin 2020;38:185-202. https://doi.org/10.1016/j.ccl.2020.01.004</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Mullens W., Damman K., HarjolaV-P., Mebazaa A., Brunner-La Rocca H-P., Martens, Testani J.M., Wilson Tang The use of diuretics in heart failure with congestion – a position statement from the Heart Failure Association of the European Society of Cardiology / European J of Heart Fail, Volume: 21, Issue: 2, Pages: 137-155. https://doi.org/10.1002/ejhf.1369</mixed-citation><mixed-citation xml:lang="en">Mullens W., Damman K., HarjolaV-P., Mebazaa A., Brunner-La Rocca H-P., Martens, Testani J.M., Wilson Tang The use of diuretics in heart failure with congestion – a position statement from the Heart Failure Association of the European Society of Cardiology / European J of Heart Fail, Volume: 21, Issue: 2, Pages: 137-155. https://doi.org/10.1002/ejhf.1369</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. https://doi.org/10.1093/eurheartj/ehab368 . Erratum in: Eur Heart J. 2021 Dec 21;42(48):4901. https://doi.org/10.1093/eurheartj/ehab368</mixed-citation><mixed-citation xml:lang="en">McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. https://doi.org/10.1093/eurheartj/ehab368 . Erratum in: Eur Heart J. 2021 Dec 21;42(48):4901. https://doi.org/10.1093/eurheartj/ehab368</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Greger R, Schlatter E. Cellular mechanism of the action of loop diuretics on the thick ascending limb of Henle's loop. Klin Wochenschr. 1983 Oct 17;61(20):1019-27. https://doi.org/10.1007/BF01537500</mixed-citation><mixed-citation xml:lang="en">Greger R, Schlatter E. Cellular mechanism of the action of loop diuretics on the thick ascending limb of Henle's loop. Klin Wochenschr. 1983 Oct 17;61(20):1019-27. https://doi.org/10.1007/BF01537500</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Ostermann M, Bellomo R, Burdmann EA, DoiK, Endre ZH, Goldstein SL, Kane-Gill SL, Liu KD, Prowle JR, Shaw AD, Srisawat N, Cheung M, Jadoul M, Winkelmayer WC, Kellum JA; Conference Participants. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 2020 Aug;98(2):294-309. https://doi.org/10.1016/j.kint.2020.04.020</mixed-citation><mixed-citation xml:lang="en">Ostermann M, Bellomo R, Burdmann EA, DoiK, Endre ZH, Goldstein SL, Kane-Gill SL, Liu KD, Prowle JR, Shaw AD, Srisawat N, Cheung M, Jadoul M, Winkelmayer WC, Kellum JA; Conference Participants. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 2020 Aug;98(2):294-309. https://doi.org/10.1016/j.kint.2020.04.020</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Wilcox CS, Testani JM, Pitt B. Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure. Hypertension. 2020 Oct;76(4):1045-1054. https://doi.org/10.1161/HYPERTENSIONAHA.120.15205</mixed-citation><mixed-citation xml:lang="en">Wilcox CS, Testani JM, Pitt B. Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure. Hypertension. 2020 Oct;76(4):1045-1054. https://doi.org/10.1161/HYPERTENSIONAHA.120.15205</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">erbrugge FH, Martens P, Ameloot K, Haemels V, Penders J, Dupont M, Tang WHW, Droogné W, Mullens W. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail. 2019 Nov;21(11):1415-1422. https://doi.org/10.1002/ejhf.1478</mixed-citation><mixed-citation xml:lang="en">erbrugge FH, Martens P, Ameloot K, Haemels V, Penders J, Dupont M, Tang WHW, Droogné W, Mullens W. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail. 2019 Nov;21(11):1415-1422. https://doi.org/10.1002/ejhf.1478</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014 Dec;4(3-4):176-88. https://doi.org/10.1159/000366168</mixed-citation><mixed-citation xml:lang="en">Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014 Dec;4(3-4):176-88. https://doi.org/10.1159/000366168</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032. https://doi.org/10.1161/cir.0000000000001063. Epub 2022 Apr 1. Erratum in: Circulation. 2022 May 3;145(18):e1033. https://doi.org/10.1161/CIR.0000000000001073. Erratum in: Circulation. 2022 Sep 27;146(13):e185. doi: 10.1161/CIR.0000000000001097 . Erratum in: Circulation. 2023 Apr 4;147(14):e674. PMID: 35363499. https://doi.org/10.1161/CIR.0000000000001142</mixed-citation><mixed-citation xml:lang="en">Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032. https://doi.org/10.1161/cir.0000000000001063. Epub 2022 Apr 1. Erratum in: Circulation. 2022 May 3;145(18):e1033. https://doi.org/10.1161/CIR.0000000000001073. Erratum in: Circulation. 2022 Sep 27;146(13):e185. doi: 10.1161/CIR.0000000000001097 . Erratum in: Circulation. 2023 Apr 4;147(14):e674. PMID: 35363499. https://doi.org/10.1161/CIR.0000000000001142</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Thind GS, Loehrke M, Wilt JL. Acute cardiorenal syndrome: Mechanisms and clinical implications. Cleve Clin J Med. 2018 Mar;85(3):231-239. PMID: 29522391. https://doi.org/10.3949/ccjm.85a.17019</mixed-citation><mixed-citation xml:lang="en">Thind GS, Loehrke M, Wilt JL. Acute cardiorenal syndrome: Mechanisms and clinical implications. Cleve Clin J Med. 2018 Mar;85(3):231-239. PMID: 29522391. https://doi.org/10.3949/ccjm.85a.17019</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019 Apr 16;139(16):e840-e878. https://doi.org/10.1161/CIR.0000000000000664</mixed-citation><mixed-citation xml:lang="en">Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019 Apr 16;139(16):e840-e878. https://doi.org/10.1161/CIR.0000000000000664</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.Nat Rev Cardiol. 2015;12:184–192. https://oi.org/10.1038/nrcardio.2014.215</mixed-citation><mixed-citation xml:lang="en">Ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.Nat Rev Cardiol. 2015;12:184–192. https://oi.org/10.1038/nrcardio.2014.215</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Testani JM, Hanberg JS, Cheng S, Rao V, Onyebeke C, Laur O, Kula A, Chen M, Wilson FP, Darlington A, et al. Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure.Circ Heart Fail. 2016;9:e002370. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002370</mixed-citation><mixed-citation xml:lang="en">Testani JM, Hanberg JS, Cheng S, Rao V, Onyebeke C, Laur O, Kula A, Chen M, Wilson FP, Darlington A, et al. Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure.Circ Heart Fail. 2016;9:e002370. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002370</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Shah N., Madanieh R., Alkan M., Dogar M.U., Kosmas C.E., Vittorio T.J. A perspective on diuretic resistance in chronic congestive heart failure. Ther Adv Cardiovasc Dis. 2017;11(10):271-278. https://doi.org/10.1177/1753944717718717</mixed-citation><mixed-citation xml:lang="en">Shah N., Madanieh R., Alkan M., Dogar M.U., Kosmas C.E., Vittorio T.J. A perspective on diuretic resistance in chronic congestive heart failure. Ther Adv Cardiovasc Dis. 2017;11(10):271-278. https://doi.org/10.1177/1753944717718717</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic Therapy for Patients with Heart Failure. Journal of the American College of Cardiology. 2020;75(10):1178–95. https://doi.org/10.1016/j.jacc.2019.12.059</mixed-citation><mixed-citation xml:lang="en">Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic Therapy for Patients with Heart Failure. Journal of the American College of Cardiology. 2020;75(10):1178–95. https://doi.org/10.1016/j.jacc.2019.12.059</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Cox ZL, Rao VS, Testani JM. Classic and Novel Mechanisms of Diuretic Resistance in Cardiorenal Syndrome. Kidney360. 2022 Mar 1;3(5):954-967. https://doi.org/10.34067/KID.0006372021</mixed-citation><mixed-citation xml:lang="en">Cox ZL, Rao VS, Testani JM. Classic and Novel Mechanisms of Diuretic Resistance in Cardiorenal Syndrome. Kidney360. 2022 Mar 1;3(5):954-967. https://doi.org/10.34067/KID.0006372021</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmad T, Jackson K, Rao VS, Tang WH, Brisco-Bacik MA, Chen HH, FelkerGM, Hernandez AF, O’Connor CM, Sabbisetti VS, Bonventre JV, Wilson FP,Coca SG, Testani JM. Worsening renal function in acute heart failure patients undergoing aggressive diuresis is not associated with tubular injury. Circulation 2018;137:2016-2028. https://doi.org/10.1161/circulationaha.117.030112</mixed-citation><mixed-citation xml:lang="en">Ahmad T, Jackson K, Rao VS, Tang WH, Brisco-Bacik MA, Chen HH, FelkerGM, Hernandez AF, O’Connor CM, Sabbisetti VS, Bonventre JV, Wilson FP,Coca SG, Testani JM. Worsening renal function in acute heart failure patients undergoing aggressive diuresis is not associated with tubular injury. Circulation 2018;137:2016-2028. https://doi.org/10.1161/circulationaha.117.030112</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Valente MA, Voors AA, Damman K, van Veldhuisen DJ, Massie BM, O’ConnorCM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG,Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL. Diureticresponse in acute heart failure: clinical characteristics and prognostic signifi-cance.Eur Heart J2014;35:1284-1293. https://doi.org/10.1093/eurheartj/ehu065</mixed-citation><mixed-citation xml:lang="en">Valente MA, Voors AA, Damman K, van Veldhuisen DJ, Massie BM, O’ConnorCM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG,Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL. Diureticresponse in acute heart failure: clinical characteristics and prognostic signifi-cance.Eur Heart J2014;35:1284-1293. https://doi.org/10.1093/eurheartj/ehu065</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Ellison DH, Felker GM. Diuretic Treatment in Heart Failure. N Engl J Med. 2017 Nov 16;377(20):1964-1975. doi: 10.1056/NEJMra1703100. Erratum in: N Engl J Med. 2018 Feb 1;378(5):492. PMID: 29141174; PMCID: PMC5811193. https://doi.org/10.1056/NEJMx180001</mixed-citation><mixed-citation xml:lang="en">Ellison DH, Felker GM. Diuretic Treatment in Heart Failure. N Engl J Med. 2017 Nov 16;377(20):1964-1975. doi: 10.1056/ NEJMra1703100. Erratum in: N Engl J Med. 2018 Feb 1;378(5):492. PMID: 29141174; PMCID: PMC5811193. https://doi.org/10.1056/NEJMx180001</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev. 2004;(1):CD003178. https://doi.org/10.1002/14651858.CD003178.pub2</mixed-citation><mixed-citation xml:lang="en">Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev. 2004;(1):CD003178. https://doi.org/10.1002/14651858.CD003178.pub2</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Oh SW, Han SY. Loop Diuretics in Clinical Practice. Electrolyte Blood Press. 2015 Jun;13(1):17-21. Epub 2015 Jun 30. https://doi.org/10.5049/EBP.2015.13.1.17</mixed-citation><mixed-citation xml:lang="en">Oh SW, Han SY. Loop Diuretics in Clinical Practice. Electrolyte Blood Press. 2015 Jun;13(1):17-21. Epub 2015 Jun 30. https://doi.org/10.5049/EBP.2015.13.1.17</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Felker GM, Lee KL, Bull DA, Redfield M.M. et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 3;364(9):797-805. https://doi.org/10.1056/NEJMoa1005419</mixed-citation><mixed-citation xml:lang="en">Felker GM, Lee KL, Bull DA, Redfield M.M. et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 3;364(9):797-805. https://doi.org/10.1056/NEJMoa1005419</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">De Bruyne LK. Mechanisms and management of diuretic resistance in congestive heart failure. Postgrad Med J. 2003 May;79(931):268- 71. PMID: 12782772; PMCID: PMC1742703. https://doi.org/10.1136/pmj.79.931.268</mixed-citation><mixed-citation xml:lang="en">De Bruyne LK. Mechanisms and management of diuretic resistance in congestive heart failure. Postgrad Med J. 2003 May;79(931):268- 71. PMID: 12782772; PMCID: PMC1742703. https://doi.org/10.1136/pmj.79.931.268</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Greene SJ, Mentz RJ. Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'? Eur J Heart Fail. 2018 Mar;20(3):471-473. Epub 2017 Oct 29. https://doi.org/10.1002/ejhf.1024</mixed-citation><mixed-citation xml:lang="en">Greene SJ, Mentz RJ. Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'? Eur J Heart Fail. 2018 Mar;20(3):471-473. Epub 2017 Oct 29. https://doi.org/10.1002/ejhf.1024</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Mirzai S, Kanaan CN, Berglund F, Mountis M, Wassif H. How do we maximize diuresis in acute decompensated heart failure? Cleve Clin J Med. 2022 Oct 3;89(10):561-565. https://doi.org/10.3949/ccjm.89a.22016</mixed-citation><mixed-citation xml:lang="en">Mirzai S, Kanaan CN, Berglund F, Mountis M, Wassif H. How do we maximize diuresis in acute decompensated heart failure? Cleve Clin J Med. 2022 Oct 3;89(10):561-565. https://doi.org/10.3949/ccjm.89a.22016</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Jardim SI, Ramos Dos Santos L, Araújo I, Marques F, Branco P, Gaspar A, Fonseca C. A 2018 overview of diuretic resistance in heart failure. Rev Port Cardiol (Engl Ed). 2018 Nov;37(11):935-945. [English, Portuguese] https://doi.org/10.1016/j.repc.2018.03.014</mixed-citation><mixed-citation xml:lang="en">Jardim SI, Ramos Dos Santos L, Araújo I, Marques F, Branco P, Gaspar A, Fonseca C. A 2018 overview of diuretic resistance in heart failure. Rev Port Cardiol (Engl Ed). 2018 Nov;37(11):935-945. [English, Portuguese] https://doi.org/10.1016/j.repc.2018.03.014</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L. et al. Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007 Mar 28;297(12):1319-31. Epub 2007 Mar 25. PMID: 17384437. https://doi.org/10.1001/jama.297.12.1319</mixed-citation><mixed-citation xml:lang="en">Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L. et al. Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007 Mar 28;297(12):1319-31. Epub 2007 Mar 25. PMID: 17384437. https://doi.org/10.1001/jama.297.12.1319</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Felker GM, Mentz RJ, Cole RT, Adams KF.Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure. J Am Coll Cardiol. 2017 Mar 21;69(11):1399-1406. Epub 2016 Sep 18. https://doi.org/10.1016/j.jacc.2016.09.004</mixed-citation><mixed-citation xml:lang="en">Felker GM, Mentz RJ, Cole RT, Adams KF.Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure. J Am Coll Cardiol. 2017 Mar 21;69(11):1399-1406. Epub 2016 Sep 18. https://doi.org/10.1016/j.jacc.2016.09.004</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Butler J., Anstrom K.J., Felker G.M., Givertz M.M. et al. Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial. JAMA Cardiol. 2017;2(9):950–958. https://doi.org/10.1001/jamacardio.2017.2198</mixed-citation><mixed-citation xml:lang="en">Butler J., Anstrom K.J., Felker G.M., Givertz M.M. et al. Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial. JAMA Cardiol. 2017;2(9):950–958. https://doi.org/10.1001/jamacardio.2017.2198</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Mullens W., Dauw J., Martens P., Verbrugge F.H. et al. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload. N Engl J Med. 2022 Sep 29;387(13):1185-1195. Epub 2022 Aug 27. https://doi.org/10.1056/NEJMoa2203094</mixed-citation><mixed-citation xml:lang="en">Mullens W., Dauw J., Martens P., Verbrugge F.H. et al. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload. N Engl J Med. 2022 Sep 29;387(13):1185-1195. Epub 2022 Aug 27. https://doi.org/10.1056/NEJMoa2203094</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Васин А.А., Миронова О.Ю., Фомин В.В. Профилактика контраст-индуцированного острого повреждения почек при внутривенном введении контрастного препарата нагрузочными дозами статинов. Евразийский Кардиологический Журнал. 2022;(3):84-88. https://doi.org/10.38109/2225-1685-2022-3-84-88</mixed-citation><mixed-citation xml:lang="en">Vasin A.A., Mironova O.I., Fomin V.V. Intravenous contrast induced acute kidney injury prevention with high doses of statins. Eurasian heart journal. 2022;(3):84-88. (In Russ.) https://doi.org/10.38109/2225-1685-2022-3-84-88</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Миронова О.Ю., Панферов А.С. Анемия хронических заболеваний: современное состояние проблемы и перспективы. Терапевтический архив. 2022;94(12):1349-1354. https://doi.org/10.26442/00403660.2022.12.201984</mixed-citation><mixed-citation xml:lang="en">Mironova OI, Panferov AS. Anemia of chronic diseases: current state of the problem and perspectives. Terapevticheskii arkhiv 2023;94(12):1349-1354. (In Russ.) https://doi.org/10.26442/00403660.2022.12.201984</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9. PMID: 15464318. https://doi.org/10.1016/j.jacc.2004.06.068</mixed-citation><mixed-citation xml:lang="en">Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9. PMID: 15464318. https://doi.org/10.1016/j.jacc.2004.06.068</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецов В.А., Миронова О.Ю., Грицанчук А.М., Фомин В.В. Контраст-ассоциированное острое повреждение почек после чрескожных коронарных вмешательств у пациентов с острым коронарным синдромом в реальной клинической практике. Consilium Medicum. 2022;24(10):713–717. https://doi.org/10.26442/20751753.2022.10.201925</mixed-citation><mixed-citation xml:lang="en">Kuznetsov VA, Mironova OI, Gritsanchuk AM, Fomin VV. Contrastassociated acute kidney injury after percutaneous coronary interventions in patients with acute coronary syndrome: a real-world study. Consilium Medicum 2022;24(10):713-717. (In Russ.) https://doi.org/10.26442/20751753.2022.10.201925</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Миронова О.Ю. Индуцированная контрастными веществами нефропатия. Терапевтический архив. 2013;85(6):с.90-95.</mixed-citation><mixed-citation xml:lang="en">Mironova O.Iu. Contrast-induced nephropathy. Therapeutic Archive. 2013;85(6):90 95. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Исаев Г.О., Миронова О.Ю., Фомин В.В. Оценка влияния различных факторов на риск развития новой коронавирусной инфекции у пациентов, перенесших контрастиндуцированное острое повреждение почек. Терапевтический архив. 2021; 93 (6): 667–671. https://doi.org/10.26442/00403660.2021.06.200861</mixed-citation><mixed-citation xml:lang="en">Isaev GO, Mironova OI, Fomin VV. Assessment of the influence of different factors on the risk of the development of a new coronavirus infection in patients with contrast induced acute kidney injury. Terapevticheskii arkhiv 2021;93(6):667-671. (In Russ.) https://doi.org/10.26442/00403660.2021.06.200861</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Васин А.А., Миронова О.Ю., Фомин В.В. Контраст-индуцированное острое повреждение почек при проведении компьютерной томографии с внутривенным введением контрастного препарата у пациентов с сердечно-сосудистыми заболеваниями. Consilium Medicum. 2021;23(12):928–930. https://doi.org/10.26442/20751753.2021.12.201162</mixed-citation><mixed-citation xml:lang="en">Vasin AA, Mironova OI, Fomin VV. Contrast-induced acute kidney injury after computed tomography with contrast media in patients with cardiovascular diseases. Consilium Medicum 2021;23(12):928- 930. (In Russ.) https://doi.org/10.26442/20751753.2021.12.201162</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Васин А.А., Миронова О.Ю., Фомин В.В. Влияние аторвастатина на профилактику контраст-индуцированного острого повреждения почек при проведении компьютерной томографии с внутривенным контрастированием. Терапевтический архив. 2022;94(9):1057-1061. https://doi.org/10.26442/00403660.2022.09.201845</mixed-citation><mixed-citation xml:lang="en">Vasin AA, Mironova OIu, Fomin VV. The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(9):1057–1061. (In Russ.) https://doi.org/10.26442/00403660.2022.09.201845</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Кисляк О.А., Подзолков В.И., Брагина А.Е., Сивакова О.А., Солнцева Т.Д., Елфимова Е.М., Валиева З.С., Фомин В.В., Миронова О.Ю. Артериальная гипертензия и хроническая болезнь почек: консенсус по ведению пациентов. Системные гипертензии. 2023;20(1):5-19. https://doi.org/10.38109/2075-082X-2023-1-5-19</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Kislyak O.A., Podzolkov V.I., Bragina A.E., Sivakova O.A., Solntseva T.D., Elfimova E.M., Valieva Z.S., Fomin V.V., Mironova O.I. Arterial hypertension and chronic kidney disease: consensus statement on patient management. Systemic Hypertension. 2023;20(1):5-19. (In Russ.) https://doi.org/10.38109/2075-082X-2023-1-5-19</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012:2;8-12. https://doi.org/10.1038/kisup.2012.7</mixed-citation><mixed-citation xml:lang="en">Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012:2;8-12. https://doi.org/10.1038/kisup.2012.7</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Щелкова Г.В., Данилов Н.М., Эркенова А.М., Яровой С.Ю., Матчин Ю.Г., Миронова О.Ю., Бобкова И.Н., Швецов М.Ю., Кисляк О.А., Чазова И.Е. Консенсус по диагностике и лечению реноваскулярной артериальной гипертонии. Системные гипертензии. 2023;20(2):5-20. https://doi.org/10.38109/2075-082X-2023-2-5-20</mixed-citation><mixed-citation xml:lang="en">Shchelkova G.V., Danilov N.M., Erkenova A.M., Yarovoy S.Yu., Matchin Yu.G., Mironova O.I., Bobkova I.N., Shvetsov M.Yu., Kislyak O.A., Chazova I.E. Consensus on renovascular hypertension: diagnosis and treatment. Systemic Hypertension. 2023;20(2):5-20. (In Russ.) https://doi.org/10.38109/2075-082X-2023-2-5-20</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Миронова О.Ю., Лакотка П.Г., Фомин В.В. Гиперурикемия как фактор риска контраст-индуцированного острого повреждения почек. Consilium Medicum. 2021;2(1):25-27. https://doi.org/10.26442/20751753.2021.1.200572</mixed-citation><mixed-citation xml:lang="en">Mironova OIu, Lakotka PG, Fomin VV. Hyperuricemia as a risk factor of contrast-induced acute kidney injury. Consilium Medicum. 2021;23(1):25-27. (In Russ.) https://doi.org/10.26442/20751753.2021.1.200572</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Аксенова А.В., Сивакова О.А., Блинова Н.В., Данилов Н.М., Елфимова Е.М., Кисляк О.А., Литвин А.Ю., Ощепкова Е.В., Фомин В.В., Чихладзе Н.М., Щелкова Г.В., Чазова И.Е. Консенсус экспертов Российского медицинского общества по артериальной гипертонии по диагностике и лечению резистентной артериальной гипертонии. Терапевтический архив. 2021;93(9):1018-1029. https://doi.org/10.26442/00403660.2021.09.201007</mixed-citation><mixed-citation xml:lang="en">Aksenova AV, Sivakova OA, Blinova NV, Danilov NM, Elfimova EM, Kisliak OA, Litvin AY, Oshchepkova EV, Fomin VV, Chikhladze NM, Shelkova GV, Chazova IE. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii arkhiv 2021;93(9):1018-1029. (In Russ.) https://doi.org/10.26442/00403660.2021.09.201007</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Чихладзе Н.М., Блинова Н.В., Белая Ж.Е., Данилов Н.М., Елфимова Е.М., Литвин А.Ю., Рожинская Л.Я., Свириденко Н.Ю., Швецов М.Ю., Азизов В.А., Григоренко Е.А., Митьковская Н.П., Мустафаев И.И., Полупанов А.Г., Сарыбаев А.Ш., Хамидуллаева Г.А. Евразийские клинические рекомендации по диагностике и лечению вторичных (симптоматических) форм артериальной гипертонии (2022). Евразийский кардиологический журнал. 2023;(1):6-65. https://doi.org/10.38109/2225-1685-2023-1-6-65</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Chikhladze N.M., Blinova N.V., Belaya Zh.E., Danilov N.M., Elfimova E.M., Litvin A.Yu., Rozhinskaya L.Ya., Sviridenko N.Yu., Shvetsov M.Yu., Azizov V.A., Grigorenko E.A., Mit’kovskaja N.P., Mustafaev I.I., Polupanov A.G., Sarybaev A.Sh., Hamidullaeva G.A. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022). Eurasian heart journal. 2023;(1):6-65. (In Russ.) https://doi.org/10.38109/2225-1685-2023-1-6-65</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Блинова Н.В., Трушина О.Ю., Кисляк О.А., Подзолков В.И., Брагина А.Е., Чазова И.Е. Консенсус по ведению пациентов с гиперурикемией и высоким сердечно-сосудистым риском: 2025. Системные гипертензии. 2025;(2):5-17. https://doi.org/10.38109/2075-082X-2025-2-5-17</mixed-citation><mixed-citation xml:lang="en">Blinova N.V., Trushina O.I., Kislyak O.A., Podzolkov V.I., Bragina A.E., Chazova I.E. Consensus on the management of patients with hyperuricemia and high cardiovascular risk: 2025. Systemic Hypertension. 2025;22(2):5-17. (In Russ.) https://doi.org/10.38109/2075-082X-2025-2-5-17</mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Копылова Ю.В., Поз Я.Л., Строков А.Г., Попцов В.Н., Воронина О.В., Ухренков С.Г. Профилактика и лечение острого повреждения почек при кардиохирургических операциях с искусственным кровообращением и трансплантации сердца. Вестник трансплантологии и искусственных органов. 2010;12(2):92-99. https://doi.org/10.15825/1995-1191-2010-2-92-99</mixed-citation><mixed-citation xml:lang="en">Kopylova Y.V., Poz Y.L., Strokov A.G., Poptsov V.N., Voronina O.V., Uhrenkov S.G. Prevention and treatment of acute kidney injury after cardiac surgery with cardiopulmonary bypass and heart transplantation. Russian Journal of Transplantology and Artificial Organs. 2010;12(2):92-99. (In Russ.) https://doi.org/10.15825/1995-1191-2010-2-92-99</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz D, Bobek I, Lentini P, Soni S, Chionh CY, Ronco C. Machines for continuous renal replacement therapy. Semin Dial. 2009 MarApr;22(2):123-32. PMID: 19426414. https://doi.org/10.1111/j.1525-139X.2008.00544.x</mixed-citation><mixed-citation xml:lang="en">Cruz D, Bobek I, Lentini P, Soni S, Chionh CY, Ronco C. Machines for continuous renal replacement therapy. Semin Dial. 2009 MarApr;22(2):123-32. PMID: 19426414. https://doi.org/10.1111/j.1525-139X.2008.00544.x</mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Macedo E, Mehta RL. Continuous Dialysis Therapies: Core Curriculum 2016. Am J Kidney Dis. 2016 Oct;68(4):645-657. Epub 2016 May 28. PMID: 27241853. https://doi.org/10.1053/j.ajkd.2016.03.427</mixed-citation><mixed-citation xml:lang="en">Macedo E, Mehta RL. Continuous Dialysis Therapies: Core Curriculum 2016. Am J Kidney Dis. 2016 Oct;68(4):645-657. Epub 2016 May 28. PMID: 27241853. https://doi.org/10.1053/j.ajkd.2016.03.427</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
